KYOTO, Japan, April 01, 2016 -- Nidec Corporation (NYSE:NJ) (the “Company”) today announced the status of the Company’s own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors held on January 21, 2016, pursuant to Article 459, Paragraph 1, Item 1 of the Company Law of Japan.
Details are as follows:
Details of Share Repurchase
1. Period of own share repurchase: From March 1, 2016 through March 31, 2016
2. Class of shares: Common stock
3. Number of own shares repurchased: 0
4. Total repurchase amount: 0 yen
Note: The above repurchase information has been prepared on the basis of execution date.
Reference
A) The following details were resolved by the Company’s Board of Directors on January 21, 2016:
1. Class of shares: Common stock
2. Total number of shares that may be repurchased: Up to 3,000,000 shares
(1.01% of total number of shares issued, excluding treasury stock)
3. Total repurchase amount: Up to 24 billion yen
4. Period of repurchase: From January 27, 2016 through January 26, 2017
B) Total number and yen amount of own shares repurchased from January 27, 2016 through March 31, 2016, pursuant to the Board of Directors resolution above:
1. Total number of own shares repurchased: 0
2. Total repurchase amount: 0 yen
Contact: Masahiro Nagayasu General Manager Investor Relations +81-75-935-6140 [email protected]


SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Reddit Emerges as a Major Winner in the Shift to AI-Powered Search
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
Tesla Poised for Breakout Year in 2026 as New Products and EV Market Reset Drive Growth
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 



